{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "SAVR patients in a randomized trial of two embolic protection devices"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 1,
        "evidence": "randomized trial of two embolic protection devices"
      },
      "Objective": {
        "score": 1,
        "evidence": "we investigated the association between epiaortic ultrasound-based atheroma grade during surgical aortic valve replacement (SAVR) and perioperative adverse outcomes"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "adverse outcomes including death, clinically apparent stroke, cerebral infarction on diffusion-weighted magnetic resonance imaging (DW-MRI), delirium, and acute kidney injury (AKI) by 7 and 30 days"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of the 383 randomized patients"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "326 (85.1%) had pre-cannulation epiaortic ultrasound data available"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "adjusted odds ratio [OR]: 2.63; 95% confidence interval [CI]: 1.24\u20135.58; p=0.01"
      },
      "Harms": {
        "score": 1,
        "evidence": "moderate/severe atheroma grade was associated with a greater risk of AKI by 7 days"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  },
  "model": "gpt-4o"
}